Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.
Nine Klebsiella pneumoniae isolates showing non-susceptibility to carbapenems were collected from three centres in the north-eastern region of Hungary. The minimum inhibitory concentrations (MICs) of antibiotics were determined by Etest. The putative production of a carbapenemase was tested by the modified Hodge test. The presence of bla (KPC) genes was verified by polymerase chain reaction (PCR) and sequencing. Furthermore, molecular typing was performed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). All isolates showed extensively drug-resistant (XDR) phenotype, and of these, eight isolates were highly resistant to colistin. The isolates carried bla (KPC-2), bla (SHV-12), bla (TEM-1) and bla (SHV-11). PFGE analysis of the nine KPC-2-producing Hungarian ST258 K. pneumoniae isolates, two KPC-2-producing Norwegian ST258 isolates and 33 CTX-M-15-producing ST11 isolates revealed the existence of one genetic cluster at an 88% similarity level. The overall results of the PFGE clustering, MLST and the presence of SHV-11 in both ST11 and ST258 suggest that this is the first hyperepidemic clonal complex of multidrug-resistant K. pneumoniae, probably CC258/CC340, possibly undergoing worldwide spread.
Tóth
A
A
Department of Bacteriology, National Center for Epidemiology, Gyáli út 2-6, 1097 Budapest, Hungary. toth.akos@oek.antsz.hu
Damjanova
I
I
Puskás
E
E
Jánvári
L
L
Farkas
M
M
Dobák
A
A
Böröcz
K
K
Pászti
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis* / Q000235:genetics; D015373:Bacterial Typing Techniques; D015780:Carbapenems / Q000494:pharmacology; D016000:Cluster Analysis; D003091:Colistin / Q000494:pharmacology*; D016172:DNA Fingerprinting; D004269:DNA, Bacterial / Q000235:genetics; D024901:Drug Resistance, Multiple, Bacterial; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D005838:Genotype; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D007710:Klebsiella Infections / Q000453:epidemiology* / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D015780:Carbapenems; D004269:DNA, Bacterial; C491478:beta-lactamase KPC-2; D001618:beta-Lactamases; D003091:Colistin
Antimicrob Agents Chemother. 2009 Aug;53(8):3365-70
19506063
J Antimicrob Chemother. 2009 Apr;63(4):654-8
19218573
Lancet Infect Dis. 2006 Sep;6(9):589-601
16931410
J Bacteriol. 2004 Mar;186(5):1518-30
14973027
Antimicrob Agents Chemother. 1997 May;41(5):943-9
9145849
Diagn Microbiol Infect Dis. 2008 Sep;62(1):102-5
18550317
Antimicrob Agents Chemother. 2009 Oct;53(10):4565-7
19620323
J Clin Microbiol. 2005 Aug;43(8):4178-82
16081970
J Clin Microbiol. 2009 Nov;47(11):3793-4
19759220
J Clin Microbiol. 2005 Jun;43(6):2551-8
15956362
PLoS One. 2009;4(3):e4982
19319196
Euro Surveill. 2008 Nov 20;13(47):
19021957
Antimicrob Agents Chemother. 2004 Jul;48(7):2400-8
15215087
Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61
11257029
J Clin Microbiol. 2007 Aug;45(8):2723-5
17581941
J Clin Microbiol. 2002 Oct;40(10):3798-801
12354884
Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9
17562800
Euro Surveill. 2009 Oct 08;14(40):
19822122
J Antimicrob Chemother. 2008 Nov;62(5):978-85
18667450
J Antimicrob Chemother. 2007 Apr;59(4):786-90
17307769
J Antimicrob Chemother. 2007 Sep;60(3):470-82
17595289